{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:15:23Z","timestamp":1773285323504,"version":"3.50.1"},"reference-count":87,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":1086,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"crossref","award":["AI 36085"],"award-info":[{"award-number":["AI 36085"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"crossref","award":["AI 27742"],"award-info":[{"award-number":["AI 27742"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH"},{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virology"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.virol.2010.06.027","type":"journal-article","created":{"date-parts":[[2010,7,23]],"date-time":"2010-07-23T03:23:03Z","timestamp":1279855383000},"page":"513-523","source":"Crossref","is-referenced-by-count":38,"title":["Structure-guided design and immunological characterization of immunogens presenting the HIV-1 gp120 V3 loop on a CTB scaffold"],"prefix":"10.1016","volume":"405","author":[{"given":"Maxim","family":"Totrov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xunqing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang-Peng","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chavdar","family":"Krachmarov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aidy","family":"Salomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constance","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael S.","family":"Seaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Cardozo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miroslaw K.","family":"Gorny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shixia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abraham","family":"Pinter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Zolla-Pazner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2010.06.027_bib2","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1006\/jmbi.1994.1052","article-title":"Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins","volume":"235","author":"Abagyan","year":"1994","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.virol.2010.06.027_bib3","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/jcc.540150503","article-title":"ICM\u2014a new method for protein modelling and design. Applications to docking and structure prediction from the distorted native conformation","volume":"15","author":"Abagyan","year":"1994","journal-title":"J. Comp. Chem."},{"key":"10.1016\/j.virol.2010.06.027_bib4","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1128\/JVI.67.4.2091-2096.1993","article-title":"Envelope-binding domain in the cationic amino acid transporter determines the host range of ecotropic murine retroviruses","volume":"67","author":"Albritton","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2010.06.027_bib5","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0378-1119(94)90152-X","article-title":"Insertion of a HIV-1-neutralizing epitope in a surface-exposed internal region of the cholera toxin B-subunit","volume":"149","author":"Backstrom","year":"1994","journal-title":"Gene"},{"key":"10.1016\/j.virol.2010.06.027_bib6","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1128\/JVI.75.12.5526-5540.2001","article-title":"The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable region","volume":"75","author":"Barnett","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2010.06.027_bib7","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nature07352","article-title":"Challenges in the development of an HIV-1 vaccine","volume":"455","author":"Barouch","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.virol.2010.06.027_bib8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0378-1119(95)00444-B","article-title":"Characterization of an internal permissive site in the cholera toxin B-subunit and insertion of epitopes from human immunodeficiency virus-1, hepatitis B virus and enterotoxigenic Escherichia coli","volume":"165","author":"Backstrom","year":"1995","journal-title":"Gene"},{"key":"10.1016\/j.virol.2010.06.027_bib9","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.jmb.2007.11.013","article-title":"Structure of antibody F425-B4e8 in complex with a V3 peptide reveals a new binding mode for HIV-1 neutralization","volume":"375","author":"Bell","year":"2008","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.virol.2010.06.027_bib10","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1002\/eji.1830231109","article-title":"An endogenously synthesized decamer peptide efficiently primes cytotoxic T cells specific for the HIV-1 envelope glycoprotein","volume":"23","author":"Bergmann","year":"1993","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.virol.2010.06.027_bib11","doi-asserted-by":"crossref","first-page":"13232","DOI":"10.1128\/JVI.78.23.13232-13252.2004","article-title":"Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies","volume":"78","author":"Binley","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2010.06.027_bib12","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00251-005-0798-y","article-title":"Automated generation and evaluation of specific MHC binding predictive tools: ARB matrix applications","volume":"57","author":"Bui","year":"2005","journal-title":"Immunogenetics"},{"key":"10.1016\/j.virol.2010.06.027_bib13","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.str.2009.09.012","article-title":"Structural basis of the cross-reactivity of genetically related human anti-HIV-1 mAbs: implications for design of V3-based immunogens","volume":"17","author":"Burke","year":"2009","journal-title":"Structure"},{"key":"10.1016\/j.virol.2010.06.027_bib14","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1089\/aid.2006.0130","article-title":"Structural basis for coreceptor selectivity by the HIV type 1 V3 loop","volume":"23","author":"Cardozo","year":"2007","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.virol.2010.06.027_bib15","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0092-8674(00)80205-6","article-title":"Core structure of gp41 from the HIV envelope glycoprotein","volume":"89","author":"Chan","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.virol.2010.06.027_bib16","doi-asserted-by":"crossref","first-page":"e8805","DOI":"10.1371\/journal.pone.0008805","article-title":"Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals","volume":"5","author":"Corti","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.virol.2010.06.027_bib17","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1021\/bc049944u","article-title":"Different immune response of mice immunized with conjugates containing multiple copies of either consensus or mixotope versions of the V3 loop peptide from human immunodeficiency virus type 1","volume":"15","author":"Cruz","year":"2004","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.virol.2010.06.027_bib18","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1021\/bc034119j","article-title":"A comparative study of different presentation strategies for an HIV peptide immunogen","volume":"15","author":"Cruz","year":"2004","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.virol.2010.06.027_bib19","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1128\/IAI.57.4.1072-1077.1989","article-title":"Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues","volume":"57","author":"Czerkinsky","year":"1989","journal-title":"Infect. Immun."},{"key":"10.1016\/j.virol.2010.06.027_bib20","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1128\/JVI.01743-08","article-title":"Human immunodeficiency virus type 2 (HIV-2)\/HIV-1 envelope chimeras detect high titers of broadly reactive HIV-1 V3-specific antibodies in human plasma","volume":"83","author":"Davis","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2010.06.027_bib21","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1107\/S0907444908013978","article-title":"Structure determination of an anti-HIV-1 Fab 447-52D-peptide complex from an epitaxially twinned data set","volume":"D64","author":"Dhillon","year":"2008","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"issue":"Pt 9","key":"10.1016\/j.virol.2010.06.027_bib22","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1099\/0022-1317-77-9-2001","article-title":"Immunogenic presentation of a conserved gp41 epitope of human immunodeficiency virus type 1 on recombinant surface antigen of hepatitis B virus","volume":"77","author":"Eckhart","year":"1996","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2010.06.027_bib23","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1128\/IAI.71.4.1740-1747.2003","article-title":"Cholera toxin and its B subunit promote dendritic cell vaccination with different influences on Th1 and Th2 development","volume":"71","author":"Eriksson","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.virol.2010.06.027_bib24","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/00002030-200301240-00003","article-title":"Candidate HIV\/AIDS vaccines: lessons learned from the world's first phase III efficacy trials","volume":"17","author":"Francis","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.virol.2010.06.027_bib25","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0378-1119(93)90643-H","article-title":"Immunological characterization of a rotavirus-neutralizing epitope fused to the cholera toxin B subunit","volume":"133","author":"Gonzalez","year":"1993","journal-title":"Gene"},{"key":"10.1016\/j.virol.2010.06.027_bib26","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1128\/JVI.78.5.2394-2404.2004","article-title":"The V3 loop is accessible on the surface of most human immunodeficiency virus type 1 primary isolates and serves as a neutralization epitope","volume":"78","author":"Gorny","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2010.06.027_bib27","doi-asserted-by":"crossref","first-page":"5114","DOI":"10.4049\/jimmunol.159.10.5114","article-title":"Human monoclonal antibodies to the V3 loop of HIV-1 with intra- and interclade cross-reactivity","volume":"159","author":"Gorny","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2010.06.027_bib28","doi-asserted-by":"crossref","first-page":"9035","DOI":"10.1128\/JVI.76.18.9035-9045.2002","article-title":"Human monoclonal antibodies specific for conformation-sensitive epitopes of V3 neutralize human immunodeficiency virus type 1 primary isolates from various clades","volume":"76","author":"Gorny","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2010.06.027_bib29","doi-asserted-by":"crossref","first-page":"6865","DOI":"10.1128\/JVI.02202-05","article-title":"Cross-clade neutralizing activity of human anti-V3 monoclonal antibodies derived from the cells of individuals infected with non-B clades of human immunodeficiency virus type 1","volume":"80","author":"Gorny","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2010.06.027_bib30","doi-asserted-by":"crossref","first-page":"635","DOI":"10.4049\/jimmunol.150.2.635","article-title":"Repertoire of neutralizing human monoclonal antibodies specific for the V3 domain of HIV-1 gp120","volume":"150","author":"Gorny","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2010.06.027_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/vir.0.82493-0","article-title":"Clinical experience with plasmid DNA- and modified vaccinia virus Ankara-vectored human immunodeficiency virus type 1 clade A vaccine focusing on T-cell induction","volume":"88","author":"Hanke","year":"2007","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2010.06.027_bib32","doi-asserted-by":"crossref","first-page":"6296","DOI":"10.1128\/JVI.71.9.6296-6304.1997","article-title":"Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor","volume":"71","author":"Hill","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2010.06.027_bib33","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.vaccine.2009.10.040","article-title":"The use of immune complex vaccines to enhance antibody responses against neutralizing epitopes on HIV-1 envelope gp120","volume":"28","author":"Hioe","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2010.06.027_bib34","doi-asserted-by":"crossref","first-page":"e10254","DOI":"10.1371\/journal.pone.0010254","article-title":"Anti-V3 monoclonal antibodies display broad neutralizing activities against multiple HIV-1 subtypes","volume":"5","author":"Hioe","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.virol.2010.06.027_bib35","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1128\/JVI.02054-06","volume":"81","author":"Honnen","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2010.06.027_bib36","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1126\/science.1118398","article-title":"Structure of a V3-containing HIV-1 gp120 core","volume":"310","author":"Huang","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.virol.2010.06.027_bib37","doi-asserted-by":"crossref","unstructured":"Jiang, X., Burke, V., Totrov, M., Williams, C., Cardozo, T., Gorny, M.K., Zolla-Pazner, C., Kong, X.-P. in press. Conserved structural elements in the V3 Crown of HIV-1 gp120 Nat. Struct. Mol. Biol.","DOI":"10.1038\/nsmb.1861"},{"key":"10.1016\/j.virol.2010.06.027_bib38","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1128\/JVI.68.1.400-410.1994","article-title":"Presentation of native epitopes in the V1\/V2 and V3 regions of human immunodeficiency virus type 1 gp120 by fusion glycoproteins containing isolated gp120 domains","volume":"68","author":"Kayman","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2010.06.027_bib39","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1128\/JVI.79.2.780-790.2005","article-title":"Antibodies that are cross-reactive for human immunodeficiency virus type 1 clade a and clade B V3 domains are common in patient sera from Cameroon, but their neutralization activity is usually restricted by epitope masking","volume":"79","author":"Krachmarov","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2010.06.027_bib40","doi-asserted-by":"crossref","first-page":"7127","DOI":"10.1128\/JVI.02619-05","article-title":"Factors determining the breadth and potency of neutralization by V3-specific human monoclonal antibodies derived from subjects infected with clade A or clade B strains of human immunodeficiency virus type 1","volume":"80","author":"Krachmarov","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2010.06.027_bib41","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1089\/08892220152741432","article-title":"V3-specific polyclonal antibodies affinity purified from sera of infected humans effectively neutralize primary isolates of human immunodeficiency virus type 1","volume":"17","author":"Krachmarov","year":"2001","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.virol.2010.06.027_bib42","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nature01188","article-title":"HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites","volume":"420","author":"Kwong","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.virol.2010.06.027_bib43","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0969-2126(00)00547-5","article-title":"Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates","volume":"8","author":"Kwong","year":"2000","journal-title":"Structure"},{"key":"10.1016\/j.virol.2010.06.027_bib44","doi-asserted-by":"crossref","first-page":"5457","DOI":"10.1128\/JVI.75.12.5457-5464.2001","article-title":"Cooperation of the V1\/V2 and V3 domains of human immunodeficiency virus type 1 gp120 for interaction with the CXCR4 receptor","volume":"75","author":"Labrosse","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2010.06.027_bib45","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1126\/science.3014647","article-title":"Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein","volume":"233","author":"Lasky","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.virol.2010.06.027_bib46","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1128\/JVI.02536-06","article-title":"Antigenic and immunogenic study of membrane-proximal external region-grafted gp120 antigens by a DNA prime-protein boost immunization strategy","volume":"81","author":"Law","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2010.06.027_bib47","series-title":"HIV Sequence Compendium","year":"2005"},{"key":"10.1016\/j.virol.2010.06.027_bib48","doi-asserted-by":"crossref","first-page":"10108","DOI":"10.1128\/JVI.79.16.10108-10125.2005","article-title":"Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies","volume":"79","author":"Li","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2010.06.027_bib49","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1111\/j.1365-2958.1991.tb00785.x","article-title":"Intranasal immunization using the B subunit of the Escherichia coli heat-labile toxin fused to an epitope of the Bordetella pertussis P.69 antigen","volume":"5","author":"Lipscombe","year":"1991","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.virol.2010.06.027_bib50","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature07159","article-title":"Molecular architecture of native HIV-1 gp120 trimers","volume":"455","author":"Liu","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.virol.2010.06.027_bib51","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.tmaid.2007.06.001","article-title":"Effectiveness in prevention of travellers' diarrhoea by an oral cholera vaccine WC\/rBS","volume":"5","author":"Lopez-Gigosos","year":"2007","journal-title":"Travel Med. Infect. Dis."},{"key":"10.1016\/j.virol.2010.06.027_bib52","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1128\/IAI.69.1.252-261.2001","article-title":"Recombinant antigen\u2013enterotoxin A2\/B chimeric mucosal immunogens differentially enhance antibody responses and B7-dependent costimulation of CD4(+) T cells","volume":"69","author":"Martin","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.virol.2010.06.027_bib53","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1016\/j.vaccine.2006.03.045","article-title":"Humoral immune responses by prime-boost heterologous route immunizations with CTB-MPR (649\u2013684), a mucosal subunit HIV\/AIDS vaccine candidate","volume":"24","author":"Matoba","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2010.06.027_bib54","doi-asserted-by":"crossref","first-page":"9709","DOI":"10.1073\/pnas.83.24.9709","article-title":"Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein","volume":"83","author":"Matthews","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virol.2010.06.027_bib55","doi-asserted-by":"crossref","first-page":"7785","DOI":"10.1128\/JVI.75.16.7785-7788.2001","article-title":"Effect of soluble CD4 on exposure of epitopes on primary, intact, native human immunodeficiency virus type 1 virions of different genetic clades","volume":"75","author":"Mbah","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2010.06.027_bib56","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1586\/14760584.7.9.1405","article-title":"Viral sequence diversity: challenges for AIDS vaccine designs","volume":"7","author":"McBurney","year":"2008","journal-title":"Expert Rev. Vaccin."},{"key":"10.1016\/j.virol.2010.06.027_bib57","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.4049\/jimmunol.133.4.1818","article-title":"Cholera toxin B subunit as a carrier protein to stimulate a mucosal immune response","volume":"133","author":"McKenzie","year":"1984","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2010.06.027_bib58","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1006\/jmbi.1998.2076","article-title":"The 1.25 \u00c5 resolution refinement of the cholera toxin B-pentamer: evidence of peptide backbone strain at the receptor-binding site","volume":"282","author":"Merritt","year":"1998","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.virol.2010.06.027_bib59","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1002\/pro.5560060716","article-title":"Structural studies of receptor binding by cholera toxin mutants","volume":"6","author":"Merritt","year":"1997","journal-title":"Protein Sci."},{"key":"10.1016\/j.virol.2010.06.027_bib60","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1128\/JVI.68.6.4031-4034.1994","article-title":"Cross-neutralizing activity against divergent human immunodeficiency virus type 1 isolates induced by the gp41 sequence ELDKWAS","volume":"68","author":"Muster","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2010.06.027_bib61","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/1471-2105-8-238","article-title":"Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method","volume":"8","author":"Nielsen","year":"2007","journal-title":"BMC Bioinform."},{"key":"10.1016\/j.virol.2010.06.027_bib62","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1089\/aid.2008.0154","article-title":"Neutralization patterns and evolution of sequential HIV type 1 envelope sequences in HIV type 1 subtype B-infected drug-naive individuals","volume":"24","author":"Nyambi","year":"2008","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.virol.2010.06.027_bib63","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.virol.2007.03.007","article-title":"Analysis of the neutralization breadth of the anti-V3 antibody F425-B4e8 and re-assessment of its epitope fine specificity by scanning mutagenesis","volume":"364","author":"Pantophlet","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.virol.2010.06.027_bib64","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.virol.2008.08.032","article-title":"Neutralizing activity of antibodies to the V3 loop region of HIV-1 gp120 relative to their epitope fine specificity","volume":"381","author":"Pantophlet","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.virol.2010.06.027_bib65","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/nm0497-366d","article-title":"HIV-1 antibody\u2014debris or virion?","volume":"3","author":"Parren","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.virol.2010.06.027_bib66","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0165-2478(97)00043-6","article-title":"Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design","volume":"57","author":"Parren","year":"1997","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.virol.2010.06.027_bib67","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s00251-005-0803-5","article-title":"The design and implementation of the immune epitope database and analysis resource","volume":"57","author":"Peters","year":"2005","journal-title":"Immunogenetics"},{"key":"10.1016\/j.virol.2010.06.027_bib68","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand","volume":"361","author":"Rerks-Ngarm","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2010.06.027_bib69","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/nature07930","article-title":"Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals","volume":"458","author":"Scheid","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.virol.2010.06.027_bib70","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.virol.2007.05.024","article-title":"Standardized assessment of NAb responses elicited in rhesus monkeys immunized with single- or multi-clade HIV-1 envelope immunogens","volume":"367","author":"Seaman","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.virol.2010.06.027_bib71","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0969-2126(03)00011-X","article-title":"Alternative conformations of HIV-1 V3 loops mimic beta hairpins in chemokines, suggesting a mechanism for coreceptor selectivity","volume":"11","author":"Sharon","year":"2003","journal-title":"Structure"},{"key":"10.1016\/j.virol.2010.06.027_bib72","doi-asserted-by":"crossref","first-page":"9434","DOI":"10.1073\/pnas.89.20.9434","article-title":"Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1","volume":"89","author":"Shioda","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virol.2010.06.027_bib73","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.str.2004.01.003","article-title":"Structural rationale for the broad neutralization of HIV-1 by human monoclonal antibody 447-52D","volume":"12","author":"Stanfield","year":"2004","journal-title":"Structure"},{"key":"10.1016\/j.virol.2010.06.027_bib74","doi-asserted-by":"crossref","first-page":"6093","DOI":"10.1128\/JVI.00205-06","article-title":"Crystal structures of human immunodeficiency virus type 1 (HIV-1) neutralizing antibody 2219 in complex with three different V3 peptides reveal a new binding mode for HIV-1 cross-reactivity","volume":"80","author":"Stanfield","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2010.06.027_bib75","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/9858","article-title":"Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices","volume":"17","author":"Sturniolo","year":"1999","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.virol.2010.06.027_bib76","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/384184a0","article-title":"CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5","volume":"384","author":"Trkola","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.virol.2010.06.027_bib77","doi-asserted-by":"crossref","DOI":"10.1126\/science.1178746","article-title":"Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target","author":"Walker","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.virol.2010.06.027_bib78","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.virol.2006.02.032","article-title":"Polyvalent HIV-1 Env vaccine formulations delivered by the DNA priming plus protein boosting approach are effective in generating neutralizing antibodies against primary human immunodeficiency virus type 1 isolates from subtypes A, B, C, D and E","volume":"350","author":"Wang","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.virol.2010.06.027_bib79","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature01470","article-title":"Antibody neutralization and escape by HIV-1","volume":"422","author":"Wei","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.virol.2010.06.027_bib80","doi-asserted-by":"crossref","first-page":"4995","DOI":"10.1016\/j.vaccine.2006.03.083","article-title":"Cross-clade recognition and neutralization by the V3 region from clade C human immunodeficiency virus-1 envelope","volume":"24","author":"Wu","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2010.06.027_bib81","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.virol.2008.07.007","article-title":"Soluble CD4 broadens neutralization of V3-directed monoclonal antibodies and guinea pig vaccine sera against HIV-1 subtype B and C reference viruses","volume":"380","author":"Wu","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.virol.2010.06.027_bib82","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.1073\/pnas.94.10.5267","article-title":"A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity","volume":"94","author":"Yamamoto","year":"1997","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.virol.2010.06.027_bib83","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1128\/JVI.78.8.4029-4036.2004","article-title":"Selective modification of variable loops alters tropism and enhances immunogenicity of human immunodeficiency virus type 1 envelope","volume":"78","author":"Yang","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2010.06.027_bib84","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1006\/jmbi.1995.0456","article-title":"The three-dimensional crystal structure of cholera toxin","volume":"251","author":"Zhang","year":"1995","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.virol.2010.06.027_bib85","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3233\/HAB-2005-143-403","article-title":"Improving on nature: focusing the immune response on the V3 loop","volume":"14","author":"Zolla-Pazner","year":"2005","journal-title":"Hum. Antibodies"},{"key":"10.1016\/j.virol.2010.06.027_bib86","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.virol.2009.05.039","article-title":"Cross-clade neutralizing antibodies against HIV-1 induced in rabbits by focusing the immune response on a neutralizing epitope","volume":"392","author":"Zolla-Pazner","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.virol.2010.06.027_bib87","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.virol.2007.09.024","article-title":"Focusing the immune response on the V3 loop, a neutralizing epitope of the HIV-1 gp120 envelope","volume":"372","author":"Zolla-Pazner","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.virol.2010.06.027_bib88","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1089\/aid.2004.20.1254","article-title":"The cross-clade neutralizing activity of a human monoclonal antibody is determined by the GPGR V3 motif of HIV type 1","volume":"20","author":"Zolla-Pazner","year":"2004","journal-title":"AIDS Res. Hum. Retroviruses"}],"updated-by":[{"DOI":"10.1016\/j.virol.2010.11.003","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2011,1,20]],"date-time":"2011-01-20T00:00:00Z","timestamp":1295481600000}}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682210004095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682210004095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T04:03:19Z","timestamp":1685678599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682210004095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":87,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0042682210004095"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2010.06.027","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}